Health In Tech, Inc.
NASDAQ:HITSoftware - Application
+$0.00 today
- Market cap
- $50.13M
- Beta
- 2.94
- P/E (TTM)
- -75.2
- EPS (TTM)
- -$0.01
Volume 0.04M
Average 0.23M
HIT Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Health In Tech, Inc.NASDAQ: HIT
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables rises 45.9% from a year ago
Net receivables stood at $8.9M at the end of Q1 FY2026, up 45.9% from a year earlier and up 76.5% from the prior quarter. Over 3 fiscal years it compounded at +72.8% a year.
Context
- Net receivables amounted to 30.7% of total assets at the end of Q1 FY2026, up 2.1 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +45.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 5.04M USD
- Year-over-year change
- +134.7%
- 3-year CAGR
- +72.8%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 5.04M | +134.7% |
| FY2024 | 2024-12-31 | 2.15M | -45.2% |
| FY2023 | 2023-12-31 | 3.92M | +301.0% |
| FY2022 | 2022-12-31 | 976.86K | — |
Net Receivables vs competitors
How HIT compares with its peers on the latest reported figures
- Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +45.9% is the highest of 8, against a peer median of +1.3%.
- Net receivables amounts to 30.7% of total assets for HIT, versus a peer median of 11.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
TEADTeads Holding Co. | Mar 2026 | $278.78M USD | -15.1% | +23.6% | 23.2% |
| Mar 2026 | $146.23M USD | +11.4% | +20.3% | 33.3% | |
LAWRRobot Consulting Co., Ltd. ADS | Sep 2025 | ¥72.21M JPY | +23.9% | +17.5% | 5.2% |
| Mar 2026 | $33.35M USD | -4.0% | -44.4% | 11.8% | |
SVCOSilvaco Group, Inc. Common Stock | Mar 2026 | $22.52M USD | +7.8% | +16.5% | 20.2% |
| Mar 2026 | $12.99M USD | +1.3% | -11.5% | 6.8% | |
HITHealth In Tech, Inc. | Mar 2026 | $8.9M USD | +45.9% | +72.8% | 30.7% |
| Dec 2025 | $7.29M USD | -48.4% | -4.8% | 10.6% | |
| Peer median (excluding HIT) | — | +1.3% | +16.5% | 11.8% | |
Competitors are the stored peer set for HIT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Health In Tech, Inc.
NASDAQ:HIT
Intrinsic Alpha fair value
Locked
Current Price
$0.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.